Enasidenib
| CAS No. | 1446502-11-9 | Cat. No. | BCP16041 |
| Name | Enasidenib | ||
| Synonyms | AG-221; AG 221; AG221; CC-90007; CC 90007; CC90007; | ||
| Formula | C19H17F6N7O | M. Wt | 473.37 |
| Description | Enasidenib, aslo known as AG-221 and CC-90007, is a potent and selective IDH2 inhibitor with potential anticancer activity (IDH2 = Isocitrate dehydrogenase 2). The mutations of IDH2 present in certain cancer cells result in a new ability of the enzyme to catalyze the NAPH-dependent reduction of α-ketoglutarate to R(-)-2-hydroxyglutarate (2HG). The production of 2HG is believed to contribute to the formation and progression of cancer . The inhibition of mutant IDH2 and its neoactivity is therefore a potential therapeutic treatment for cancer. | ||
| Pathways | Protease/Metabolic Enzyme | ||
| Targets | IDH | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.